A randomized controlled trial on triple diuretics in peritoneal dialysis

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

TCTR

Registry ID

TCTR20140625002

Enrollment

Registered

2014-06-25

Start date

2014-06-02

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

peritoneal dialysis patients diuretic drugs residual urine small solute clearance

Interventions

give triple diuretic drugs (furosemide&#44

spironolactone&#44

thiazide)to PD patients,give single diuretic drugs (furosemide)to PD patients

Experimental Drug,Placebo Comparator Drug

triple diuretic,single diuretic+placebo

Eligibility

Sex/Gender

All

Age

15 Years to 90 Years

Inclusion criteria

Inclusion criteria: peritoneal dialysis patients who follow up in CAPD clinic Burapha hospital

Exclusion criteria

Exclusion criteria: allergy of diuretic drugs severe hypotension can not collected residual urine eg neurogenic bladder

Design outcomes

Primary

Measure	Time frame
urine volume 6 month randomized control trial: measure urine volume per day	—

Secondary

Measure	Time frame
small solute clearance 6 month urine urea, urine creatinine urine Na	—

Countries

Thailand

Contacts

Public ContactRaweewan Witoon

Buapha University

r_aumy@hotmail.com038394850

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026